🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Standard placebo-controlled, double-blind study design (TEV-50717 \[low dos...
Status
Completed
Location
Teva Investigational Site 060-0160
Start Date
2018-05-31
Trial ID
NCT03571256
The purpose of this study is to determine whether SD-809 tablets are effect...
Status
Completed
Location
Teva Investigational Site 057
Start Date
2013-08-05
Trial ID
NCT01795859
This is an otherwise open-label, single-arm study that includes a 2-week, d...
Status
Terminated
Location
Teva Investigational Site 046-0104
Start Date
2018-05-25
Trial ID
NCT03567291
To determine the efficacy of deutetrabenazine to control symptoms of dyspha...
Status
Terminated
Location
Fundacion Huntington Puerto Rico, Inc. - Huntington's disease Clinic
Start Date
2022-01-21
Trial ID
NCT04301726
Treatments Being Tested
CP (cerebral palsy) refers to a group of neurological disorders that appear...
Status
Completed
Location
Teva Investigational Site 14137
Start Date
2019-08-06
Trial ID
NCT03813238
The purpose of this study is to evaluate the safety, tolerability, and phar...
Status
Completed
Location
Teva Investigational Site 057
Start Date
2013-11-12
Trial ID
NCT01897896
Treatments Being Tested
This is a single-center, open-label study of AUSTEDO in study subjects with...
Status
Completed
Location
University of Pennsylvania
Start Date
2021-04-29
Trial ID
NCT04173260
Treatments Being Tested
This is a study to evaluate the efficacy and safety of deutetrabenazine (TE...
Status
Completed
Location
Teva Investigational Site 046-0104
Start Date
2018-02-05
Trial ID
NCT03452943
The purpose of this study is to determine whether fixed-doses of an investi...
Status
Completed
Location
Teva Investigational Site 145
Start Date
2014-10-31
Trial ID
NCT02291861
Study TV50717-CNS-30081 is a 55-week study in which participants who have s...
Status
Terminated
Location
Teva Investigational Site 14137
Start Date
2020-02-04
Trial ID
NCT04200352
Treatments Being Tested